These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11974431)

  • 21. Use of sulfonylurea agents in older diabetic patients.
    Peters AL; Davidson MB
    Clin Geriatr Med; 1990 Nov; 6(4):903-21. PubMed ID: 2224754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin.
    Petrak F; Herpertz S; Stridde E; Pfützner A
    Diabetes Technol Ther; 2013 Aug; 15(8):703-11. PubMed ID: 23844571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting sulfonylureas -- long-acting hypoglycaemia.
    Veitch PC; Clifton-Bligh RJ
    Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes.
    Ferrannini E
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):25-39. PubMed ID: 22575405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative hypoglycemia in a patient receiving insulin detemir.
    Olson RP; Bethel MA; Lien L
    Anesth Analg; 2009 Jun; 108(6):1836-8. PubMed ID: 19448209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin therapy in type II diabetes: who needs it, how much of it, and for how long?
    Skyler JS
    Postgrad Med; 1997 Feb; 101(2):85-90, 92-4, 96. PubMed ID: 9046928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for insulin therapy in type 2 diabetes.
    Edelman SV; Morello CM
    South Med J; 2005 Mar; 98(3):363-71. PubMed ID: 15813164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes. Paradoxical effects of tightly controlled blood sugar.
    Taubes G
    Science; 2008 Oct; 322(5900):365-7. PubMed ID: 18927369
    [No Abstract]   [Full Text] [Related]  

  • 30. [An analysis of the causes of low-efficacy treatment in type-2 diabetes mellitus using sulfonylurea derivatives].
    Gendeleka GF
    Lik Sprava; 1996; (3-4):100-3. PubMed ID: 9035838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulin monotherapy in patients with diabetes mellitus type 2 developing secondary resistance to sulfanilamide preparations].
    Gendeleka GF
    Lik Sprava; 2000 Mar; (2):72-4. PubMed ID: 10862482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Principles of diabetes mellitus type 2 therapy regarding some aspects of insulin deficiency development].
    Vernyhorods'kyĭ VS
    Lik Sprava; 2004; (3-4):72-5. PubMed ID: 15318832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of postprandial hyperglycemia].
    Iwamoto Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():721-6. PubMed ID: 9434554
    [No Abstract]   [Full Text] [Related]  

  • 34. Non-insulin-dependent diabetes mellitus. Current status of oral hypoglycemic therapy.
    Nelson RL
    Postgrad Med; 1987 May; 81(6):177-81, 184-6. PubMed ID: 3554200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of the hypoglycemic preparation gliquidone in patients with digestive organ diseases combined with diabetes mellitus].
    Degtiareva II; Lodianaia EV; Opanasiuk ND; Palladina OL
    Lik Sprava; 1995; (7-8):84-7. PubMed ID: 8846383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors for development of secondary failure to sulfonylurea drugs in non-insulin-dependent diabetes mellitus.
    Borissova AM; Koev DG; Minev MG; Martinova FG; Gencova PI; Kirilov GG; Arnaudov J
    Acta Diabetol Lat; 1991; 28(1):91-8. PubMed ID: 1862695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination insulin-sulfonylurea therapy in type II diabetes mellitus.
    Allen BT; Feinglos MN
    South Med J; 1987 Oct; 80(10):1285-9. PubMed ID: 3310252
    [No Abstract]   [Full Text] [Related]  

  • 38. When to use insulin in the maturity onset diabetic.
    Tattersall RB; Scott AR
    Postgrad Med J; 1987 Oct; 63(744):859-64. PubMed ID: 3328848
    [No Abstract]   [Full Text] [Related]  

  • 39. Improved insulin sensitivity and metabolic control in type 2 diabetes does not influence plasma homocysteine.
    Pouwels MJ; Den Heijer M; Blom HJ; Tack CJ; Hermus AR
    Diabetes Care; 2003 May; 26(5):1637-9. PubMed ID: 12716838
    [No Abstract]   [Full Text] [Related]  

  • 40. [Glurenorm in the treatment of patients with non-insulin-dependent diabetes mellitus with diseases of the liver and bile ducts].
    Balabolkin MI; Nedosugova LV
    Probl Endokrinol (Mosk); 1993; 39(4):16-8. PubMed ID: 8415521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.